EMA Authorised: Travatan (travoprost) — Novartis Europharm Limited

View source ↗

Summary

EU marketing authorisation granted for Travatan eye drops (travoprost) by Novartis Europharm Limited for glaucoma (open-angle) and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travatan (travoprost)

Snippet

Status: Authorised. Therapeutic area: Glaucoma, Open-Angle;Ocular Hypertension. MAH: Novartis Europharm Limited. Decision date: 22/01/2026